Tradename | Company | Number | Date | Products |
---|---|---|---|---|
POMALYST | Bristol Myers Squibb | N-204026 RX | 2013-02-08 | 4 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
pomalyst | New Drug Application | 2025-02-26 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
multiple myeloma | — | D009101 | C90.0 |
Expiration | Code | ||
---|---|---|---|
POMALIDOMIDE, POMALYST, BRISTOL | |||
2027-11-14 | PED | ||
2027-05-14 | ODE-296, ODE-297 | ||
2024-05-20 | PED | ||
2023-11-20 | M-14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 5 | 12 | 1 | — | 1 | 16 |
Plasma cell neoplasms | D054219 | — | — | 5 | 10 | 1 | — | 1 | 14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 1 | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | 1 | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | 1 | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | — | 1 | — | — | — | 1 |
Amyloidosis | D000686 | EFO_1001875 | E85 | — | 1 | — | — | — | 1 |
Drug common name | Pomalidomide |
INN | pomalidomide |
Description | Pomalidomide is an aromatic amine that is thalidomide substituted at position 4 on the isoindole ring system by an amino group. Used for the treatment of multiple myeloma in patients who failed to respond to previous therapies. It has a role as an antineoplastic agent, an immunomodulator and an angiogenesis inhibitor. It is a dicarboximide, a member of isoindoles, a member of piperidones and an aromatic amine. It is functionally related to a thalidomide. |
Classification | Small molecule |
Drug class | thalidomide derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O |
PDB | — |
CAS-ID | 19171-19-8 |
RxCUI | — |
ChEMBL ID | CHEMBL43452 |
ChEBI ID | 72690 |
PubChem CID | 134780 |
DrugBank | DB08910 |
UNII ID | D2UX06XLB5 (ChemIDplus, GSRS) |